{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:59:27Z","timestamp":1789631967304,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.vaccine.2011.11.093","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T08:34:00Z","timestamp":1334997240000},"page":"A30-A35","source":"Crossref","is-referenced-by-count":65,"special_numbering":"S1","title":["Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines"],"prefix":"10.1016","volume":"30","author":[{"given":"Manish","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Duncan","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh D.","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"June (23)","key":"10.1016\/j.vaccine.2011.11.093_bib0005","first-page":"220","article-title":"Meeting of the immunization Strategic Advisory Group of Experts, April 2009 \u2013 conclusions and recommendations","volume":"84","author":"WHO","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.093_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.093_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"August (32)","key":"10.1016\/j.vaccine.2011.11.093_bib0020","first-page":"285","article-title":"Rotavirus vaccines","volume":"82","author":"WHO","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"August (9741)","key":"10.1016\/j.vaccine.2011.11.093_bib0025","first-page":"606","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2011","journal-title":"Lancet"},{"issue":"August (9741)","key":"10.1016\/j.vaccine.2011.11.093_bib0030","first-page":"615","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2011","journal-title":"Lancet"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.11.093_bib0035","article-title":"Performance of rotavirus vaccines in developed and developing countries","volume":"6","author":"Jiang","year":"2010","journal-title":"Hum Vaccine"},{"issue":"November (9601)","key":"10.1016\/j.vaccine.2011.11.093_bib0040","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"issue":"April (9619)","key":"10.1016\/j.vaccine.2011.11.093_bib0045","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(08)60524-3","article-title":"Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study","volume":"371","author":"Linhares","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2011.11.093_bib0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1473-3099(11)70253-5","article-title":"2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis","volume":"12","author":"Tate","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2011.11.093_bib0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"issue":"January (1 Suppl)","key":"10.1016\/j.vaccine.2011.11.093_bib0060","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/INF.0b013e3181fefa1f","article-title":"Real-world impact of rotavirus vaccination","volume":"30","author":"Patel","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"November (200 Suppl)","key":"10.1016\/j.vaccine.2011.11.093_bib0065","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1086\/605035","article-title":"Oral rotavirus vaccines: how well will they work where they are needed most?","volume":"1","author":"Patel","year":"2009","journal-title":"J Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.11.093_bib0070","first-page":"252","article-title":"Problems with oral poliovaccine in India","volume":"9","author":"John","year":"1972","journal-title":"Indian Pediatr"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2011.11.093_bib0075","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.11.093_bib0080","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/IAI.61.9.3994-3997.1993","article-title":"Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels","volume":"61","author":"Gotuzzo","year":"1993","journal-title":"Infect Immun"},{"issue":"November (1\u20132)","key":"10.1016\/j.vaccine.2011.11.093_bib0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0264-410X(02)00348-1","article-title":"Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children","volume":"21","author":"Hallander","year":"2002","journal-title":"Vaccine"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2011.11.093_bib0090","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/315051","article-title":"Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR","volume":"180","author":"Lagos","year":"1999","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.11.093_bib0095","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/605330","article-title":"Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India","volume":"200","author":"Grassly","year":"2009","journal-title":"J Infect Dis"},{"issue":"September (Suppl 1)","key":"10.1016\/j.vaccine.2011.11.093_bib0100","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/infdis\/174.Supplement_1.S107","article-title":"Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines","volume":"174","author":"Rennels","year":"1996","journal-title":"J Infect Dis"},{"issue":"February (Suppl 1)","key":"10.1016\/j.vaccine.2011.11.093_bib0105","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/infdis\/175.Supplement_1.S258","article-title":"The effect of diarrhea on oral poliovirus vaccine failure in Brazil","volume":"175","author":"Posey","year":"1997","journal-title":"J Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.11.093_bib0110","first-page":"1097","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine","volume":"171","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.093_bib0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4615-3838-7_33","article-title":"Ing RT. Immune response to rotavirus vaccines among breast-fed and nonbreast-fed children","volume":"310","author":"Glass","year":"1991","journal-title":"Adv Exp Med Biol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.11.093_bib0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00006454-199603000-00006","article-title":"Effect of diarrhea on the humoral response to oral polio vaccination","volume":"15","author":"Myaux","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2011.11.093_bib0125","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2009.10.032","article-title":"CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation","volume":"28","author":"Ahmed","year":"2009","journal-title":"Vaccine"},{"issue":"September (39)","key":"10.1016\/j.vaccine.2011.11.093_bib0130","first-page":"6542","article-title":"Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines","volume":"28","author":"Steele","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.093_bib0135","unstructured":"WHO. Available at: http:\/\/apps.who.int\/immunization_monitoring\/en\/globalsummary\/scheduleselect.cfm [accessed 03.04.11]."},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.11.093_bib0140","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/INF.0b013e3181782780","article-title":"Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine","volume":"27","author":"Ciarlet","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2011.11.093_bib0145","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/INF.0b013e3182138278","article-title":"Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America","volume":"30","author":"Tregnaghi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2011.11.093_bib0150","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.vaccine.2008.12.059","article-title":"Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age","volume":"27","author":"Zaman","year":"2009","journal-title":"Vaccine"},{"issue":"September (Suppl)","key":"10.1016\/j.vaccine.2011.11.093_bib0155","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1086\/653550","article-title":"Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants","volume":"202","author":"Steele","year":"2010","journal-title":"J Infect Dis"},{"issue":"December (50)","key":"10.1016\/j.vaccine.2011.11.093_bib0160","first-page":"533","article-title":"Rotavirus vaccines: an update","volume":"84","author":"WHO","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2011.11.093_bib0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0264-410X(97)00210-7","article-title":"Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12","volume":"16","author":"Bernstein","year":"1998","journal-title":"Vaccine"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.11.093_bib0170","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1086\/514076","article-title":"Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group","volume":"176","author":"Ward","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.093_bib0175","unstructured":"GlaxoSmithKline, Clinical Study Register. Available at http:\/\/www.gsk-clinicalstudyregister.com\/index.jsp [accessed 25.10.11]."},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.11.093_bib0220","doi-asserted-by":"crossref","first-page":"A44","DOI":"10.1016\/j.vaccine.2011.08.080","article-title":"Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial","volume":"30","author":"Madhi","year":"2012","journal-title":"Vaccine"},{"issue":"January (10)","key":"10.1016\/j.vaccine.2011.11.093_bib0185","first-page":"7","article-title":"Safety and efficacy of high-dose rhesus\u2013human reassortant rotavirus vaccines \u2013 report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group","volume":"97","author":"Rennels","year":"1996","journal-title":"Pediatrics"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2011.11.093_bib0190","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.11.093_bib0195","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1586\/erv.09.106","article-title":"Intussusception and rotavirus vaccination: a review of the available evidence","volume":"8","author":"Patel","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2011.11.093_bib0200","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.11.093_bib0205","unstructured":"WHO. Statement on Rotarix and Rotateq vaccines and intussusception. Available at: http:\/\/www.who.int\/vaccine_safety\/topics\/rotavirus\/rotarix_and_rotateq\/intussusception_sep2010\/en\/index.html [accessed 01.10.10]."},{"issue":"16","key":"10.1016\/j.vaccine.2011.11.093_bib0215","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T06:45:38Z","timestamp":1594017938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11018895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":42,"alternative-id":["S0264410X11018895"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.093","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}